GALT Competitors & Alternatives
Compare Galectin Therapeutics Inc with similar stocks in the same industry
Biotechnology
GALT
Main Stock$2.32
Tradestie Score
53
Market Cap
$267.77M
Analyst Upside
+374.1%
Top Competitors
228 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
TRDA
Entrada Therapeutics, Inc. Common Stock
|
$12.89
|
$223.66M | - | 51 | Compare |
|
SLS
SELLAS Life Sciences Group, Inc. Common Stock
|
$4.88
|
$211.22M | - | 55 | Compare |
|
ACRS
Aclaris Therapeutics, Inc.
|
$4.22
|
$202.58M | - | 64 | Compare |
|
CBIO
Crescent Biopharma, Inc. Common Stock
|
$23.96
|
$199.71M | - | 58 | Compare |
|
FBRX
Forte Biosciences, Inc. Common Stock
|
$26.39
|
$180.53M | - | 57 | Compare |
|
STTK
Shattuck Labs, Inc. Common Stock
|
$7.53
|
$114.01M | - | 61 | Compare |
|
ANRO
Alto Neuroscience Inc.
|
$24.47
|
$110.20M | - | 57 | Compare |
|
LITS
Lite Strategy, Inc. Common Stock
|
$1.14
|
$91.28M | - | 61 | Compare |
|
STRO
Sutro Biopharma, Inc.
|
$34.69
|
$76.55M | - | 54 | Compare |
|
RLMD
Relmada Therapeutics, Inc. Common Stock
|
$7.24
|
$71.69M | - | 58 | Compare |
More GALT Analysis
Data updated: Apr 29, 2026 | Industry: Biotechnology (SIC 2834)
228 stocks in this industry